Combining EGFR targeted therapy with chemotherapy in pancreatic cancer: is timing important?

Cancer Biol Ther. 2005 Oct;4(10):1096-7. doi: 10.4161/cbt.4.10.2102. Epub 2005 Oct 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Drug Administration Schedule
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / therapeutic use*
  • Erlotinib Hydrochloride
  • Gefitinib
  • Humans
  • Pancreatic Neoplasms / drug therapy*
  • Quinazolines / administration & dosage*
  • Quinazolines / therapeutic use

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors
  • Gefitinib